GlassScriptPhysician profile
Joseph B Schneider
NPI 1811013576
$13,285.22
in general payments reported to CMS, 2019-2025
41 companies · $2,349 in 2025
The $2,349 reported for 2025 was more than what 80% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,261 · 2020: $1,461 · 2021: $1,363 · 2022: $1,459 · 2023: $1,772 · 2024: $2,621 · 2025: $2,349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,732 · Education: $9.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,732.02 |
| Education | $9.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,654.12 | 2019-2025 | Skyrizi, Rinvoq |
| Novartis Pharmaceuticals Corporation | $1,578.91 | 2019-2025 | |
| Lilly USA, LLC | $924.78 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Sun Pharmaceutical Industries INC. | $845.19 | 2019-2025 | Winlevi, Ilumya, Blu-U |
| Organogenesis INC. | $806.42 | 2019-2025 | Via Matrix, Puraply, Simplimax |
| E.R. Squibb & Sons, L.L.C. | $663.34 | 2022-2025 | Sotyktu |
| Ucb, INC. | $649.25 | 2019-2025 | Bimzelx, Cimzia |
| Amgen INC. | $577.17 | 2019-2025 | Otezla, Otezla |
| Janssen Biotech, INC. | $568.46 | 2021-2025 | Tremfya |
| Leo Pharma INC. | $542.02 | 2020-2024 | Adbry |
| Prugen, INC. Pharmaceuticals | $412.66 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $381.39 | 2019-2025 | Libtayo, Dupixent |
| Genzyme Corporation | $348.34 | 2019-2025 | |
| Dermavant Sciences, INC. | $325.90 | 2022-2024 | Vtama |
| Pfizer INC. | $323.02 | 2019-2025 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Schneider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.